• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXP4-AS1 通过 USP10 稳定的 PD-L1 促进 CD8 T 细胞耗竭和食管癌免疫逃逸。

FOXP4-AS1 promotes CD8 T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.

机构信息

Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, No. 59, Shengli West Road, Xiangcheng District, Zhangzhou City, 363000, Fujian Province, China.

出版信息

Immunol Res. 2024 Aug;72(4):766-775. doi: 10.1007/s12026-024-09482-9. Epub 2024 Apr 30.

DOI:10.1007/s12026-024-09482-9
PMID:38687433
Abstract

Esophageal cancer (EC) is the 9th most frequently diagnosed malignancy globally with unfavorable prognosis. Immune escape is one of the principal factors leading to poor survival, however, the mechanism underlying immune escape remains largely uninvestigated. The xenograft mouse model and EC cell-CD8 cytotoxic T lymphocytes (CTLs) co-culture system were established. Immunohistochemistry, qRT-PCR or western blot were employed to detect the levels of long non-coding RNA (lncRNA) FOXP4-AS1, PD-L1, USP10 and other molecules. The abundance of T cells, cytokine production and cell apoptosis were monitored by flow cytometry. The viability of CTLs was assessed by Trypan blue staining. The binding between FOXP4-AS1 and USP10 was validated by RNA pull-down assay, and the interaction between USP10 and PD-L1, as well as the ubiquitination of PD-L1, were detected by co-immunoprecipitation. The elevation of FOXP4-AS1 in EC was associated with decreased CTL abundance, and upregulated PD-L1 facilitated CTL apoptosis in EC. FOXP4-AS1 accelerated EC tumor growth by decreasing the abundance of tumor infiltrating CTLs in vivo. FOXP4-AS1 inhibited the viability of CTLs and facilitated the cytotoxicity and exhaustion of CTLs. In Kyse 450 cell-CTL co-culture system, FOXP4-AS1 suppressed the viability and abundance of CTLs, and inhibited EC cell apoptosis via PD-L1. Mechanistically, FOXP4-AS1 regulated the ubiquitination of PD-L1 through deubiquitinating enzyme USP10. FOXP4-AS1 promoted CTL exhaustion and EC immune escape through USP10-stabilized PD-L1. HIGHLIGHTS: PD-L1 facilitated CD8 T cell apoptosis in EC. Upregulated FOXP4-AS1 promoted EC tumor growth by inhibiting the viability and facilitating the cytotoxicity and exhaustion of tumor infiltrating CD8 T cells. FOXP4-AS1 suppressed the viability and abundance of CD8 T cells through USP10-mediated deubiquitination of PD-L1.

摘要

食管癌(EC)是全球第 9 大常见恶性肿瘤,预后不良。免疫逃逸是导致不良生存的主要因素之一,但免疫逃逸的机制在很大程度上仍未得到研究。建立了异种移植小鼠模型和 EC 细胞与 CD8 细胞毒性 T 淋巴细胞(CTL)共培养系统。采用免疫组织化学、qRT-PCR 或 Western blot 检测长链非编码 RNA(lncRNA)FOXP4-AS1、PD-L1、USP10 等分子的水平。通过流式细胞术监测 T 细胞的丰度、细胞因子的产生和细胞凋亡。采用台盼蓝染色法评估 CTL 的活力。通过 RNA 下拉实验验证 FOXP4-AS1 与 USP10 的结合,通过共免疫沉淀检测 USP10 与 PD-L1 的相互作用以及 PD-L1 的泛素化。EC 中 FOXP4-AS1 的升高与 CTL 丰度的降低有关,上调的 PD-L1 促进 EC 中 CTL 的凋亡。FOXP4-AS1 通过减少体内肿瘤浸润 CTL 的丰度促进 EC 肿瘤生长。FOXP4-AS1 抑制 CTL 的活力,并促进 CTL 的细胞毒性和耗竭。在 Kyse 450 细胞-CTL 共培养系统中,FOXP4-AS1 抑制 CTL 的活力和丰度,并通过 PD-L1 抑制 EC 细胞凋亡。机制上,FOXP4-AS1 通过去泛素化酶 USP10 调节 PD-L1 的泛素化。FOXP4-AS1 通过 USP10 稳定的 PD-L1 促进 CTL 耗竭和 EC 免疫逃逸。要点:PD-L1 促进 EC 中 CD8 T 细胞凋亡。上调的 FOXP4-AS1 通过抑制肿瘤浸润 CD8 T 细胞的活力和促进其细胞毒性和耗竭来促进 EC 肿瘤生长。FOXP4-AS1 通过 USP10 介导的 PD-L1 去泛素化来抑制 CD8 T 细胞的活力和丰度。

相似文献

1
FOXP4-AS1 promotes CD8 T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.FOXP4-AS1 通过 USP10 稳定的 PD-L1 促进 CD8 T 细胞耗竭和食管癌免疫逃逸。
Immunol Res. 2024 Aug;72(4):766-775. doi: 10.1007/s12026-024-09482-9. Epub 2024 Apr 30.
2
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.长链非编码 RNA SNHG12 通过 HuR/PD-L1/USP8 轴调控非小细胞肺癌免疫逃逸的分子机制。
Cell Mol Biol Lett. 2022 Jun 3;27(1):43. doi: 10.1186/s11658-022-00343-7.
3
lncRNA EGFR-AS1 facilitates leiomyosarcoma progression and immune escape via the EGFR-MYC-PD-L1 axis.长链非编码 RNA EGFR-AS1 通过 EGFR-MYC-PD-L1 轴促进平滑肌肉瘤的进展和免疫逃逸。
Int Immunol. 2022 Jul 4;34(7):365-377. doi: 10.1093/intimm/dxac014.
4
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10.NDR1 通过 USP10 介导 PD-L1 去泛素化以促进前列腺癌免疫逃逸。
Cell Commun Signal. 2024 Sep 3;22(1):429. doi: 10.1186/s12964-024-01805-5.
5
LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.长链非编码 RNA MALAT1 通过海绵吸附 miR-195 促进弥漫性大 B 细胞淋巴瘤的发生和免疫逃逸。
Life Sci. 2019 Aug 15;231:116335. doi: 10.1016/j.lfs.2019.03.040. Epub 2019 Mar 18.
6
N-methyladenosine-modified circIGF2BP3 inhibits CD8 T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.N6-甲基腺苷修饰的环状 IGF2BP3 通过促进非小细胞肺癌中 PD-L1 的去泛素化来抑制 CD8 T 细胞反应,从而促进肿瘤免疫逃逸。
Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4.
7
LncRNA OIP5-AS1 Knockdown Facilitated the Ferroptosis and Immune Evasion by Modulating the GPX4 in Oesophageal Carcinoma.长链非编码 RNA OIP5-AS1 通过调节食管癌细胞中的 GPX4 促进铁死亡和免疫逃逸。
Comput Math Methods Med. 2022 Jul 15;2022:8103198. doi: 10.1155/2022/8103198. eCollection 2022.
8
FOXA1/UBE2T Inhibits CD8T Cell Activity by Inducing Mediates Glycolysis in Lung Adenocarcinoma.FOXA1/UBE2T 通过诱导肺腺癌中的糖酵解来抑制 CD8T 细胞的活性。
Front Biosci (Landmark Ed). 2024 Apr 1;29(4):134. doi: 10.31083/j.fbl2904134.
9
miR-186-5p Down-Regulates PD-L1 Level in Acute Myeloid Leukemia Cells and Inhibits Tumorigenesis and Immune Escape.miR-186-5p下调急性髓系白血病细胞中PD-L1水平并抑制肿瘤发生和免疫逃逸。
J Biochem Mol Toxicol. 2025 May;39(5):e70278. doi: 10.1002/jbt.70278.
10
CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1.环状核纤层蛋白1(CircNF1)通过对程序性死亡受体配体1(PD-L1)的双重调控来调节食管鳞状细胞癌的进展和免疫逃逸。
Cell Mol Biol Lett. 2025 Mar 29;30(1):37. doi: 10.1186/s11658-025-00712-y.

引用本文的文献

1
Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape.揭示食管鳞状细胞癌中的免疫检查点耐药性:对肿瘤微环境和生物标志物格局的见解
World J Gastrointest Oncol. 2025 Aug 15;17(8):109489. doi: 10.4251/wjgo.v17.i8.109489.
2
Functions and mechanisms of long non-coding RNA in esophageal squamous cell carcinoma (Review).长链非编码RNA在食管鳞状细胞癌中的作用及机制(综述)
Oncol Lett. 2025 Jul 1;30(3):418. doi: 10.3892/ol.2025.15164. eCollection 2025 Sep.
3
Causal relationship between circulating immune cells and the risk of esophageal cancer: a Mendelian randomization study.

本文引用的文献

1
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.食管鳞状细胞癌中的免疫逃逸:从肿瘤微环境的角度来看
Front Oncol. 2023 Jan 9;12:1096717. doi: 10.3389/fonc.2022.1096717. eCollection 2022.
2
Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.靶向 USP10 诱导食管鳞癌细胞中致癌性 ANLN 的降解。
Cell Death Differ. 2023 Feb;30(2):527-543. doi: 10.1038/s41418-022-01104-x. Epub 2022 Dec 16.
3
FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta-Analysis and Bioinformatics Analysis.
循环免疫细胞与食管癌风险之间的因果关系:一项孟德尔随机化研究
Discov Oncol. 2025 Feb 21;16(1):220. doi: 10.1007/s12672-025-01921-9.
4
Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From molecular biology to clinical application.长链非编码RNA FOXP4-AS1在人类癌症中的新作用:从分子生物学到临床应用
Heliyon. 2024 Oct 26;10(21):e39857. doi: 10.1016/j.heliyon.2024.e39857. eCollection 2024 Nov 15.
FOXP4-AS1可能是人类癌症中一种潜在的预后生物标志物:一项荟萃分析和生物信息学分析
Front Oncol. 2022 May 26;12:799265. doi: 10.3389/fonc.2022.799265. eCollection 2022.
4
Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21.外泌体程序性死亡配体1通过上调信号转导和转录激活因子3/微小RNA-21赋予食管癌细胞化学抗性并促进其致瘤特性。
Gene Ther. 2023 Feb;30(1-2):88-100. doi: 10.1038/s41434-022-00331-8. Epub 2022 Apr 19.
5
The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target.泛癌中USP10的预后价值及免疫浸润:一个潜在的治疗靶点
Front Oncol. 2022 Mar 31;12:829705. doi: 10.3389/fonc.2022.829705. eCollection 2022.
6
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.免疫检查点抑制剂的肿瘤免疫疗法;优缺点。
Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y.
7
Long Non-Coding RNA in Esophageal Cancer: A Review of Research Progress.长链非编码 RNA 在食管癌中的研究进展综述。
Pathol Oncol Res. 2022 Feb 15;28:1610140. doi: 10.3389/pore.2022.1610140. eCollection 2022.
8
LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4.长链非编码RNA FOXP4-AS1通过与MLL2/H3K4me3相互作用上调FOXP4促进食管鳞状细胞癌进展。
Front Oncol. 2021 Dec 14;11:773864. doi: 10.3389/fonc.2021.773864. eCollection 2021.
9
Advances and challenges in the treatment of esophageal cancer.食管癌治疗的进展与挑战
Acta Pharm Sin B. 2021 Nov;11(11):3379-3392. doi: 10.1016/j.apsb.2021.03.008. Epub 2021 Mar 9.
10
Trends of Esophageal Cancer Incidence and Mortality and Its Influencing Factors in China.中国食管癌发病率、死亡率趋势及其影响因素
Risk Manag Healthc Policy. 2021 Nov 30;14:4809-4821. doi: 10.2147/RMHP.S312790. eCollection 2021.